Medical Care
Global Personalized Medicines In Oncology Market Research Report 2025
- Jul 08, 25
- ID: 347571
- Pages: 89
- Figures: 87
- Views: 1
The global market for Personalized Medicines In Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines In Oncology.
The Personalized Medicines In Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicines In Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicines In Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc
Segment by Type
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others
Segment by Application
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicines In Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines In Oncology.
The Personalized Medicines In Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicines In Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicines In Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc
Segment by Type
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others
Segment by Application
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicines In Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2020-2031)
2.2 Global Personalized Medicines In Oncology Growth Trends by Region
2.2.1 Global Personalized Medicines In Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Medicines In Oncology Historic Market Size by Region (2020-2025)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031)
2.3 Personalized Medicines In Oncology Market Dynamics
2.3.1 Personalized Medicines In Oncology Industry Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2020-2025)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2024
3.5 Global Key Players of Personalized Medicines In Oncology Head office and Area Served
3.6 Global Key Players of Personalized Medicines In Oncology, Product and Application
3.7 Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2020-2025)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031)
5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2020-2025)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2020-2031)
6.2 North America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Medicines In Oncology Market Size by Country (2020-2025)
6.4 North America Personalized Medicines In Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2020-2031)
7.2 Europe Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Medicines In Oncology Market Size by Country (2020-2025)
7.4 Europe Personalized Medicines In Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2020-2031)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2020-2031)
9.2 Latin America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2020-2031)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Details
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Details
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Details
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Details
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Details
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.12.5 Exagen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2020-2031)
2.2 Global Personalized Medicines In Oncology Growth Trends by Region
2.2.1 Global Personalized Medicines In Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Medicines In Oncology Historic Market Size by Region (2020-2025)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031)
2.3 Personalized Medicines In Oncology Market Dynamics
2.3.1 Personalized Medicines In Oncology Industry Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2020-2025)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2024
3.5 Global Key Players of Personalized Medicines In Oncology Head office and Area Served
3.6 Global Key Players of Personalized Medicines In Oncology, Product and Application
3.7 Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2020-2025)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031)
5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2020-2025)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2020-2031)
6.2 North America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Medicines In Oncology Market Size by Country (2020-2025)
6.4 North America Personalized Medicines In Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2020-2031)
7.2 Europe Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Medicines In Oncology Market Size by Country (2020-2025)
7.4 Europe Personalized Medicines In Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2020-2031)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2020-2031)
9.2 Latin America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2020-2031)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Details
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Details
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Details
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Details
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Details
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.12.5 Exagen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Personalized Medicines In Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Personalized Medicines In Oncology Market Share by Region (2020-2025)
Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Personalized Medicines In Oncology Market Share by Region (2026-2031)
Table 14. Personalized Medicines In Oncology Market Trends
Table 15. Personalized Medicines In Oncology Market Drivers
Table 16. Personalized Medicines In Oncology Market Challenges
Table 17. Personalized Medicines In Oncology Market Restraints
Table 18. Global Personalized Medicines In Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Personalized Medicines In Oncology Market Share by Players (2020-2025)
Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Personalized Medicines In Oncology, Headquarters and Area Served
Table 24. Global Key Players of Personalized Medicines In Oncology, Product and Application
Table 25. Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Medicines In Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2020-2025)
Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2026-2031)
Table 31. Global Personalized Medicines In Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2020-2025)
Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2026-2031)
Table 35. North America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Personalized Medicines In Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 50. Biotheranostics Company Details
Table 51. Biotheranostics Business Overview
Table 52. Biotheranostics Personalized Medicines In Oncology Product
Table 53. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 54. Biotheranostics Recent Development
Table 55. Illumina Company Details
Table 56. Illumina Business Overview
Table 57. Illumina Personalized Medicines In Oncology Product
Table 58. Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 59. Illumina Recent Development
Table 60. DNA Link Company Details
Table 61. DNA Link Business Overview
Table 62. DNA Link Personalized Medicines In Oncology Product
Table 63. DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 64. DNA Link Recent Development
Table 65. Genomic Health, Inc.(Exact Sciences) Company Details
Table 66. Genomic Health, Inc.(Exact Sciences) Business Overview
Table 67. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
Table 68. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 69. Genomic Health, Inc.(Exact Sciences) Recent Development
Table 70. Cypher Genomics(Human Longevity, Inc.) Company Details
Table 71. Cypher Genomics(Human Longevity, Inc.) Business Overview
Table 72. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
Table 73. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 74. Cypher Genomics(Human Longevity, Inc.) Recent Development
Table 75. Life Technologies Corporation(Thermo Fisher Scientific) Company Details
Table 76. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
Table 77. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
Table 78. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 79. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
Table 80. Fulgent Genetics Company Details
Table 81. Fulgent Genetics Business Overview
Table 82. Fulgent Genetics Personalized Medicines In Oncology Product
Table 83. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 84. Fulgent Genetics Recent Development
Table 85. Caris Life Sciences Company Details
Table 86. Caris Life Sciences Business Overview
Table 87. Caris Life Sciences Personalized Medicines In Oncology Product
Table 88. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 89. Caris Life Sciences Recent Development
Table 90. Ariana Pharma Company Details
Table 91. Ariana Pharma Business Overview
Table 92. Ariana Pharma Personalized Medicines In Oncology Product
Table 93. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 94. Ariana Pharma Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Personalized Medicines In Oncology Product
Table 98. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. deCODE genetics Company Details
Table 101. deCODE genetics Business Overview
Table 102. deCODE genetics Personalized Medicines In Oncology Product
Table 103. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 104. deCODE genetics Recent Development
Table 105. Exagen Inc Company Details
Table 106. Exagen Inc Business Overview
Table 107. Exagen Inc Personalized Medicines In Oncology Product
Table 108. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 109. Exagen Inc Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. Personalized Medicines In Oncology Picture
Figure 2. Global Personalized Medicines In Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Medicines In Oncology Market Share by Type: 2024 VS 2031
Figure 4. Molecular Oncopathology Features
Figure 5. Genome Diagnostics Features
Figure 6. Radiation Therapy Features
Figure 7. Oncology Testing Features
Figure 8. Chemotherapy Features
Figure 9. Others Features
Figure 10. Global Personalized Medicines In Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Personalized Medicines In Oncology Market Share by Application: 2024 VS 2031
Figure 12. Research Centers Case Studies
Figure 13. Governmental Institutions Case Studies
Figure 14. Hospitals Case Studies
Figure 15. Clinical Centers Case Studies
Figure 16. Others Case Studies
Figure 17. Personalized Medicines In Oncology Report Years Considered
Figure 18. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Personalized Medicines In Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Personalized Medicines In Oncology Market Share by Region: 2024 VS 2031
Figure 21. Global Personalized Medicines In Oncology Market Share by Players in 2024
Figure 22. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2024
Figure 24. North America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 26. United States Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 30. Germany Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2020-2031)
Figure 38. China Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 46. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 50. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 54. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 55. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 56. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 57. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 58. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 59. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 60. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 61. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 62. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 63. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 64. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Others
Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Personalized Medicines In Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Personalized Medicines In Oncology Market Share by Region (2020-2025)
Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Personalized Medicines In Oncology Market Share by Region (2026-2031)
Table 14. Personalized Medicines In Oncology Market Trends
Table 15. Personalized Medicines In Oncology Market Drivers
Table 16. Personalized Medicines In Oncology Market Challenges
Table 17. Personalized Medicines In Oncology Market Restraints
Table 18. Global Personalized Medicines In Oncology Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Personalized Medicines In Oncology Market Share by Players (2020-2025)
Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Personalized Medicines In Oncology, Headquarters and Area Served
Table 24. Global Key Players of Personalized Medicines In Oncology, Product and Application
Table 25. Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Personalized Medicines In Oncology Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2020-2025)
Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2026-2031)
Table 31. Global Personalized Medicines In Oncology Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2020-2025)
Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2026-2031)
Table 35. North America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Personalized Medicines In Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
Table 50. Biotheranostics Company Details
Table 51. Biotheranostics Business Overview
Table 52. Biotheranostics Personalized Medicines In Oncology Product
Table 53. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 54. Biotheranostics Recent Development
Table 55. Illumina Company Details
Table 56. Illumina Business Overview
Table 57. Illumina Personalized Medicines In Oncology Product
Table 58. Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 59. Illumina Recent Development
Table 60. DNA Link Company Details
Table 61. DNA Link Business Overview
Table 62. DNA Link Personalized Medicines In Oncology Product
Table 63. DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 64. DNA Link Recent Development
Table 65. Genomic Health, Inc.(Exact Sciences) Company Details
Table 66. Genomic Health, Inc.(Exact Sciences) Business Overview
Table 67. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
Table 68. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 69. Genomic Health, Inc.(Exact Sciences) Recent Development
Table 70. Cypher Genomics(Human Longevity, Inc.) Company Details
Table 71. Cypher Genomics(Human Longevity, Inc.) Business Overview
Table 72. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
Table 73. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 74. Cypher Genomics(Human Longevity, Inc.) Recent Development
Table 75. Life Technologies Corporation(Thermo Fisher Scientific) Company Details
Table 76. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
Table 77. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
Table 78. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 79. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
Table 80. Fulgent Genetics Company Details
Table 81. Fulgent Genetics Business Overview
Table 82. Fulgent Genetics Personalized Medicines In Oncology Product
Table 83. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 84. Fulgent Genetics Recent Development
Table 85. Caris Life Sciences Company Details
Table 86. Caris Life Sciences Business Overview
Table 87. Caris Life Sciences Personalized Medicines In Oncology Product
Table 88. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 89. Caris Life Sciences Recent Development
Table 90. Ariana Pharma Company Details
Table 91. Ariana Pharma Business Overview
Table 92. Ariana Pharma Personalized Medicines In Oncology Product
Table 93. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 94. Ariana Pharma Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Personalized Medicines In Oncology Product
Table 98. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. deCODE genetics Company Details
Table 101. deCODE genetics Business Overview
Table 102. deCODE genetics Personalized Medicines In Oncology Product
Table 103. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 104. deCODE genetics Recent Development
Table 105. Exagen Inc Company Details
Table 106. Exagen Inc Business Overview
Table 107. Exagen Inc Personalized Medicines In Oncology Product
Table 108. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
Table 109. Exagen Inc Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. Personalized Medicines In Oncology Picture
Figure 2. Global Personalized Medicines In Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Medicines In Oncology Market Share by Type: 2024 VS 2031
Figure 4. Molecular Oncopathology Features
Figure 5. Genome Diagnostics Features
Figure 6. Radiation Therapy Features
Figure 7. Oncology Testing Features
Figure 8. Chemotherapy Features
Figure 9. Others Features
Figure 10. Global Personalized Medicines In Oncology Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Personalized Medicines In Oncology Market Share by Application: 2024 VS 2031
Figure 12. Research Centers Case Studies
Figure 13. Governmental Institutions Case Studies
Figure 14. Hospitals Case Studies
Figure 15. Clinical Centers Case Studies
Figure 16. Others Case Studies
Figure 17. Personalized Medicines In Oncology Report Years Considered
Figure 18. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Personalized Medicines In Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Personalized Medicines In Oncology Market Share by Region: 2024 VS 2031
Figure 21. Global Personalized Medicines In Oncology Market Share by Players in 2024
Figure 22. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2024
Figure 24. North America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 26. United States Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 30. Germany Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2020-2031)
Figure 38. China Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 46. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2020-2031)
Figure 50. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 54. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 55. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 56. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 57. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 58. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 59. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 60. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 61. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 62. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 63. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 64. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232